Czechia, Feb. 3 -- Czechia based Janssen-Cilag s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Antineoplastic and immunomodulating agents - Monoclonal antibody - Daratumumab I. The value of the contract is worth 1100909860 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....